The dynamic range of circulating tumor DNA in metastatic breast cancer

INTRODUCTION: The management of metastatic breast cancer needs improvement. As clinical evaluation is not very accurate in determining the progression of disease, the analysis of circulating tumor DNA (ctDNA) has evolved to a promising noninvasive marker of disease evolution. Indeed, ctDNA was repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Heidary, Maryam, Auer, Martina, Ulz, Peter, Heitzer, Ellen, Petru, Edgar, Gasch, Christin, Riethdorf, Sabine, Mauermann, Oliver, Lafer, Ingrid, Pristauz, Gunda, Lax, Sigurd, Pantel, Klaus, Geigl, Jochen B, Speicher, Michael R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303230/
https://www.ncbi.nlm.nih.gov/pubmed/25107527
http://dx.doi.org/10.1186/s13058-014-0421-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303230/
https://www.ncbi.nlm.nih.gov/pubmed/25107527
http://dx.doi.org/10.1186/s13058-014-0421-y

Ejemplares similares